pocketful logo light
pocketful logo light
Metropolis Healthcare Ltd logo

Metropolis Healthcare Ltd

NSE: METROPOLIS BSE: 542650

556.95

(2.99%)

Tue, 25 Aug 2026, 07:58 am

Metropolis Healthcare Share Price Live Chart

1 Day

(2.99%)

No Result Found

Summary

  • Market Cap (in Cr)

    11462.35

  • Net Profit (in Cr)

    145.51

  • P/B

    6.12

  • Sector P/E

    58.57

  • P/E

    55.83

  • EV/EBITDA

    25.51

  • Debt/Equity (Industry)

    0.18

  • Interest Cover (Industry)

    12.19

  • ROCE (Industry)

    17.69

  • RONW (Industry)

    14.86

  • ROE

    11.99

  • ROCE

    14.96

  • Debt/Equity

    0.17

  • EPS (TTM)

    9.48

  • Dividend Yield

    0

  • Book Value

    72.98

  • Interest Cover

    8.99

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters48.8748.8848.8948.8948.90
FII10.4311.6912.5212.8315.29
DII35.7934.7333.1032.4030.30
Public4.914.715.495.885.52
Government00000

Read More

Technical Analysis

RSI

52.34

MACD

-2.13

50 DMA

560.72

200 DMA

503.79

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic728.60651.55617574.50539.95497.45420.40
Fibonacci651.55622.12603.93574.50545.07526.88497.45
Camarilla603.64596.58589.51574.50575.39568.32561.26

Pivots Level: Classic

R3

+154.10

728.60

R2

+77.05

651.55

R1

+42.50

617

574.50
574.50
Pivot Point
LTP: 566.50

S1

-34.55

539.95

S2

-77.05

497.45

S3

-154.10

420.40

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    558.80

  • 20-EMA

    561.28

  • 30-EMA

    561.14

  • 50-EMA

    555.76

  • 100-EMA

    538.23

  • 200-EMA

    517.03

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
13 May 2026dividend₹1.00 Dividend /Share19 May 2026
13 May 2026board-meetingsAccounts, Interim Dividend
11 Mar 2026bonus3:1 Bonus Issue of Equity Shares20 Mar 2026
04 Feb 2026board-meetingsQuarterly Results
04 Nov 2025board-meetingsQuarterly Results, Interim Dividend
04 Nov 2025dividend₹4.00 Dividend /Share11 Nov 2025
11 Oct 2025dividendInterim Dividend - Rs. - 411 Nov 2025
22 Jul 2025agm
31 Jul 2024agm
04 Nov 2023dividend₹4.00 Dividend /Share17 Nov 2023

Read More

Peer Comparison

Metropolis Healthcare Ltd logo

Metropolis Healthcare Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Read More

Metropolis Healthcare Ltd About

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Industry

Healthcare

Founded

2000

Headquarters

CEO

Ameera Sushil Shah

Employees

Contact

Website icon

Website

http://www.metropolisindia.com

Email icon

Email

investor.relations@metropolisindia.com

Phone icon

Phone

91-22-62582810

Location icon

Location

250 D Udyog Bhavan, Worli, Mumbai, Maharashtra, 400030

Read More

Metropolis Healthcare Ltd Company History

YearHistory
2017
  • Metropolis Healthcare acquired Sanjeevani Pathology Laboratory in Rajkot.
2018
  • Metropolis Healthcare executed a Public-Private partnership agreement with the National AIDS Control Organisation, Government of India.
  • Metropolis Healthcare implemented the Scheme of Amalgamation 2018.
  • Metropolis Healthcare incorporated a subsidiary in Tanzania.
  • Metropolis Healthcare was awarded for 'Best in Health and Fitness' in the Digital Campaign Awards by LH Insights.
  • Metropolis Healthcare was awarded for 'Excellence in Customer Service & Delivery' by Biotrains.
  • Metropolis Healthcare received a special jury mention for 'Service Excellence (Diagnostic Centre)' by FICCI at the Healthcare Excellence Awards.
2020
  • Metropolis Healthcare won the India CSR award for the 'Too Shy To Ask' App.
  • Metropolis Healthcare was awarded India Diagnostic Service Provider Company of the year 2020.
2021
  • Metropolis Healthcare completed the acquisition of Hitech Diagnostic Centre.
  • Metropolis Healthcare's Board of Directors approved the acquisition of Dr. Ganesan's Hitech Diagnostic Centre.
2024
  • Metropolis Healthcare Limited completed the acquisition of Metropolis Foundation.
  • Metropolis Healthcare Limited acquired a 100% stake in Core Diagnostics Private Limited.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
CORE DIAGNOSTICS (MAURITIUS) PRIVATE LIMITEDbulkSell2924571905.1104 Dec 2025
GOLDMAN SACHS (SINGAPORE) PTE.- ODIblockSell55000194416 Oct 2025
GOLDMAN SACHS BANK EUROPESE - ODIblockBuy55000194416 Oct 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell2808251683.4921 Dec 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy2596251690.3821 Dec 2023
GRANDEUR PEAK GLOBAL TRUST GRANDEUR PEAK GLOBAL OPPORTUNITIES FUNDblockBuy1576201509.9520 Oct 2023
GRANDEUR PEAK INTERNATIONAL OPPORTUNITIES FUNDblockSell2430111509.9520 Oct 2023
GRANDEUR PEAK GLOBAL TRUST GRANDEUR PEAK GLOBAL REACH FUNDblockBuy386411509.9520 Oct 2023
GRANDEUR PEAK EMERGING MARKETS OPPORTUNITIES FUNDblockSell2753521509.9520 Oct 2023
GRANDEUR PEAK GLOBAL TRUST GRANDEUR PEAK INTERNATIONAL OPPORTUNITIES FUNDblockBuy2430111509.9520 Oct 2023

Read More

Metropolis Healthcare Ltd News

Metropolis Healthcare Q1FY27 Earnings Call on Aug 5

Metropolis Healthcare will host a Q1FY27 earnings conference call on August 5, 2026, at 09:00 AM IST, organized by JM Financial Institutional Securities Limited.

28 Jul 2026

companies

Metropolis Healthcare FY26: Revenue up 24%, PAT rises 31% to ₹191 crore

Metropolis Healthcare reported a 24% rise in consolidated revenue to ₹1,646 crore for FY26. Net profit surged 31% to ₹191 crore, driven by specialty diagnostics growth and successful acquisition integration.

28 Jul 2026

companies

Metropolis Healthcare files FY26 BRSR report

Metropolis Healthcare Limited has submitted its Business Responsibility and Sustainability Report for FY26, detailing ESG targets, workforce diversity, and environmental initiatives across its diagnostic network.

27 Jul 2026

companies

Metropolis Healthcare Posts 16% Revenue Growth in Q1 FY27

Metropolis Healthcare reports 16% YoY revenue growth in Q1 FY27, driven by higher patient volumes, better revenue realizations, improved EBITDA margins, and strong Truhealth Wellness and Specialty segment performance.

06 Jul 2026

companies

Metropolis Healthcare confirms no new encumbrance on promoter shares

Metropolis Healthcare promoters confirmed no new encumbrance on shares in FY26. Metz Advisory LLP holds 12 lakh encumbered shares.

23 Jun 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number